Skip to main content
Clinical Trials/NCT04274660
NCT04274660
Completed
Not Applicable

Evaluation of the Diabetes and WELLbeing (DWELL) Programme for People With Type 2 Diabetes

Canterbury Christ Church University5 sites in 4 countries594 target enrollmentSeptember 8, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Canterbury Christ Church University
Enrollment
594
Locations
5
Primary Endpoint
Change in diabetes self-management as assessed by the Diabetes Self-Care Activities Measure
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study evaluates the impact of 'DWELL' - a 12-week psycho-social education programme designed to help people with type 2 diabetes to better self-manage their condition. Up to 600 patients will participate in the programme, while a non-intervention group will receive routine care for their diabetes

Detailed Description

The DWELL (Diabetes and WELLbeing) 12-week programme has been designed to incorporate specific elements of diabetes education and is underpinned by motivational interviewing to ensure it is tailored to individuals. Each of the four elements of the programme - education, nutrition, physical activity and wellbeing - have been carefully selected based on previous research into diabetes education. The Canterbury Christ Church University (CCCU) DWELL Team are responsible for the evaluation of DWELL, which will explore whether the combination of the programme elements is effective in improving self-management. Additionally, a process evaluation and cost effectiveness analysis will be conducted alongside participant outcomes The programme will be delivered at five sites (two in the UK, one in Belgium, one in France, one in the Netherlands). The CCCU DWELL research team will be responsible for quality assurance, management and analysis of data, sample size assessment and reporting of adverse events. Each delivery site is responsible for adhering to their own Standard Operating Procedures.

Registry
clinicaltrials.gov
Start Date
September 8, 2017
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of type 2 diabetes
  • Over the age of 18

Exclusion Criteria

  • Under the age of 18
  • Pregnant women
  • Individuals who do not have the mental capacity to participate

Outcomes

Primary Outcomes

Change in diabetes self-management as assessed by the Diabetes Self-Care Activities Measure

Time Frame: Baseline, end of programme (3 months), 6 months after programme, 12 months after programme

Changes in self-management and self-care will be measured using the Diabetes Self-Care Activities Measure at four time points. The SDSCA assesses aspects of the diabetes regimen. Higher scores indicate greater taking of prescribed medication and undertaking footcare regime.

Secondary Outcomes

  • Change in levels of physical activity as assessed by the International Physical Activity Questionnaire (IPAQ)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in waist circumference(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in eating behaviour as assessed by the Dutch Eating Behaviour Questionnaire (DEBQ)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in quality of life as assessed by the Short Form Health Survey (SF-12)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in illness perception as assessed by the Illness Perception Questionnaire (IPQ-R)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in Body Mass Index (BMI) as assessed by height and weight(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Change in psychosocial self-efficacy as assessed by the Diabetes Empowerment Scale (DES-SF)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Quality Adjusted Life Years (QALYs)(2.5 years)
  • Change in average blood glucose levels as assessed by Hemoglobin A1c levels (HbA1c)(Baseline, end of programme (3 months), 6 months after programme, 12 months after programme)
  • Cost effectiveness(2.5 years)

Study Sites (5)

Loading locations...

Similar Trials